Congratulations to MSD innovators at OxTALENT 2017

12 July 2017

The OxTALENT annual awards recognise members of the University who have made innovative use of digital technology in learning/teaching and outreach/public engagement.

MSD innovators took all three places on the podium in the Public Engagement category [http://blogs.it.ox.ac.uk/oxtalent/2996]

Winners: Andrew Pollard, Sarah Loving & Yama Farooq for The Vaccine Knowledge Project

Runners-up: Scott Billings, Ellena Smith, Kate Nation, Jacqueline Pumphrey, Zoltan Molnar & Holly Bridge for Brain Diaries

Honourable Mention: Chris Paton, Mike English, Hilary Edgcombe, Niall Winters, Anne Geniets & Jakob Rossner for LIFE: Life-Saving Instruction for Emergencies

MSD also received awards in:

Innovative teaching and learning with technology [http://blogs.it.ox.ac.uk/oxtalent/2990]

Joint Runners-up: Nicola Barclay, Simon Kyle, Colin Espie, Christopher-James Harvey, Sumathi Sekaran & Damion Young for The Oxford online programme in Sleep Medicine

Honourable Mention: Jennifer Brown for Development of ‘Virtual Microscopy’ and online assessment modules for the Laboratory Medicine course

Innovation Challenges [http://blogs.it.ox.ac.uk/oxtalent/3033]

Runner-up: Jon Mason for Chooser: Simple, flexible option choosing

AIMday in Women's Health - registration for academics now open

8 April 2021

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

Innovation award for Professor Anindita Roy to develop new treatments for childhood cancer

18 March 2021

Associate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of £4.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children’s and young people’s cancers, with the hope of finding new ways to prevent and treat these complex cancers.

Oxford vaccine creator Professor Sarah Gilbert awarded RSA Albert Medal

5 March 2021

Professor Sarah Gilbert has been awarded the Royal Society for Arts, Manufactures and Commerce’ (RSA) Albert Medal for her work on the Oxford vaccine.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

25 February 2021

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

16 February 2021

The University of Oxford announced today that it has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

BioEscalator’s Enara Bio partners with Boehringer Ingelheim to develop novel cancer immunotherapies

4 February 2021

Enara Bio, a start-up located in the University’s BioEsclator, has announced a strategic collaboration and licensing agreement with Boehringer Ingelheim, worth over €876M (£787M), to lead the discovery and validation of Dark Antigens to target lung and gastrointestinal cancers.